Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs

MLA

Roberto Viviani, and Julia C. Stingl. “Polymorphism in CYP2D6 and CYP2C19, Members of the Cytochrome P450 Mixed-Function Oxidase System, in the Metabolism of Psychotropic Drugs.” Journal of Internal Medicine, vol. 277, no. 2, Oct. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....372faa47261de61c29d7be92b993bac4&authtype=sso&custid=ns315887.

APA

Roberto Viviani, & Julia C. Stingl. (2014). Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. Journal of Internal Medicine, 277(2).

Chicago

Roberto Viviani, and Julia C. Stingl. 2014. “Polymorphism in CYP2D6 and CYP2C19, Members of the Cytochrome P450 Mixed-Function Oxidase System, in the Metabolism of Psychotropic Drugs.” Journal of Internal Medicine 277 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....372faa47261de61c29d7be92b993bac4&authtype=sso&custid=ns315887.